Bioblast Pharma Ltd (ORPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORPN | XRTX | FNCH | ||
| Company | Bioblast Pharma Ltd | Xortx Therapeutics Inc | Finch Therapeutics Group Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.82 | 2.52 | 2.34 | ||
| High | 11.50 | 2.70 | 2.64 | ||
| Low | 10.32 | 2.52 | 2.34 | ||
| Last | 11.50 | 2.52 | 2.46 | ||
| Change | +0.72 | -0.04 | +0.15 | ||
| % Change | +6.68% | -1.56% | +6.53% | ||
| Volume | 19,700 | 3,091 | 44,366 | ||
| 20-Day Average Volume | 25,821 | 15,435 | 100,407 | ||
| Previous Close | 10.78 | 2.56 | 2.31 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 11.19 | 3.10 | 2.37 | ||
| 20-Day Raw Stochastic | 31.30% | 6.38% | 34.77% | ||
| 20-Day Relative Strength | 53.88% | 41.13% | 48.64% | ||
| Weighted Alpha | -18.50 | -52.03 | -77.31 | ||
| Today's Opinion | 56% Buy | 56% Sell | 80% Sell | ||
| Previous Opinion | 40% Buy | 56% Sell | 96% Sell | ||
| Last Month's Opinion | 8% Sell | 16% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.28% since 03/18/19 | +0.39% since 04/25/24 | +6.47% since 04/25/24 | ||
| Low | 10.32 on 03/25/19 | 2.52 on 05/02/24 | 2.10 on 04/26/24 | ||
| High | 11.74 on 03/21/19 | 3.24 on 04/29/24 | 2.43 on 05/02/24 | ||
| 1-Month | |||||
| %Chg | +5.70% since 02/25/19 | -22.96% since 04/02/24 | -3.05% since 04/02/24 | ||
| Low | 9.45 on 03/06/19 | 2.51 on 04/25/24 | 1.86 on 04/12/24 | ||
| High | 16.00 on 03/07/19 | 3.92 on 04/09/24 | 3.37 on 04/16/24 | ||
| 3-Month | |||||
| %Chg | +63.35% since 12/24/18 | +16.59% since 02/02/24 | -11.17% since 02/02/24 | ||
| Low | 6.16 on 12/31/18 | 2.20 on 02/14/24 | 1.86 on 04/12/24 | ||
| High | 17.36 on 02/19/19 | 7.00 on 03/07/24 | 4.46 on 03/11/24 | ||
| 6-Month | |||||
| %Chg | +6.09% since 09/25/18 | -6.81% since 11/02/23 | -35.28% since 11/02/23 | ||
| Low | 6.16 on 12/31/18 | 1.98 on 12/27/23 | 1.86 on 04/12/24 | ||
| High | 18.40 on 10/18/18 | 7.00 on 03/07/24 | 5.70 on 12/01/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,805 | 5,120 | 3,708 | ||
| Shares Outstanding, K | 418 | 1,999 | 1,606 | ||
| Annual Sales | 0 | 0 | 110,000 | ||
| Annual Net Income | -5,950,000 | -2,160,000 | -74,750,000 | ||
| Last Quarter Sales | N/A | 0 | 0 | ||
| Last Quarter Net Income | N/A | 2,700,000 | -1,450,000 | ||
| 60-Month Beta | 1.41 | 0.74 | 0.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.48 on 04/02/24 | -1.89 on 03/25/24 | ||
| Latest Earnings Date | 04/22/19 | 05/20/24 | 05/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 01/31/14 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||